This is the first Paxlovid trial out looking at whether Paxlovid would work for Long COVID treatment with the thinking that if the theory of a viral reservoir, or viral persistence is causing the illness then a drug that reduces the virus should help reduce the symptoms. The results of this trial have been talked
Unite to Fight | We envision a world free of Long Covid & ME/CFS stigmatization, where every individual can thrive.
Diagnosing, measuring, and treating Long COVID is complicated, as it can present differently from person to person and persist for months or years
Functional limitations and cardiovascular symptoms in long COVID. This research focuses on investigating long COVID, particularly the cardiovascular symptoms and functional limitations associated with the condition.
Dr. Abigail Koppes, Associate Professor of Chemical Engineering at Northeastern University, shares her journey of navigating academia with Long Covid.
Mast cell activation, a key component of the immune system, has been increasingly recognized as a significant contributor to the symptomatology of Long COVID. Mast cells play a crucial role in the body’s defense against pathogens and in regulating allergic responses and can manifest as persistent fatigue, brain fog, headaches, gastrointestinal issues, skin rashes, joint
A recent study published in Brain reveals that individuals suffering from long-term COVID-19 may experience significant cognitive issues for over a year. Conducted during the first wave of the pandemic, the research compared patients with ongoing symptoms to those who had fully recovered. Read More...
Battling Long Covid: The Ongoing Struggle for Those Testing Negative but Still Suffering
The presence of poor attention in long COVID sheds light on the cognitive complexities of post-acute sequelae, emphasizing the need for tailored cognitive support and a nuanced approach to address the diverse challenges faced by individuals on the path to recovery.
Cardiovascular autonomic dysfunction (CVAD) is a significant aspect of post-COVID-19 syndrome, affecting approximately one-third of highly symptomatic COVID-19 patients, and proper management is crucial for patient well-being